DADC
WST icon

D.A. Davidson & Co’s West Pharmaceutical WST Stock Holding History

D.A. Davidson & Co’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$213K Sell
849
-17
-2% -$4.23K ﹤0.01% 1470
2025
Q4 		$238K Sell
866
-11
-1% -$3.01K ﹤0.01% 1397
2025
Q3 		$230K Buy
+877
New +$213K ﹤0.01% 1404
2025
Q1 		– Sell
-899
Closed -$294K – 1509
2024
Q4 		$294K Sell
899
-11
-1% -$3.46K ﹤0.01% 1210
2024
Q3 		$273K Buy
910
+2
+0.2% +$612 ﹤0.01% 1215
2024
Q2 		$299K Sell
908
-3
-0.3% -$1.06K ﹤0.01% 1165
2024
Q1 		$360K Buy
911
+9
+1% +$3.33K ﹤0.01% 1110
2023
Q4 		$318K Buy
902
+22
+3% +$7.79K ﹤0.01% 1104
2023
Q3 		$330K Hold
880
– – ﹤0.01% 1051
2023
Q2 		$337K Buy
+880
New +$314K ﹤0.01% 1060
2019
Q2 		– Sell
-4,247
Closed -$468K – 1156
2019
Q1 		$468K Buy
+4,247
New +$442K 0.01% 720
2017
Q3 		– Sell
-629
Closed -$59K – 1993
2017
Q2 		$59K Buy
+629
New +$57.9K ﹤0.01% 1479
2017
Q1 		– Sell
-533
Closed -$45K – 2510
2016
Q4 		$45K Sell
533
-11
-2% -$865 ﹤0.01% 1638
2016
Q3 		$40K Hold
544
– – ﹤0.01% 1615
2016
Q2 		$41K Sell
544
-34
-6% -$2.47K ﹤0.01% 1490
2016
Q1 		$40K Sell
578
-1,837
-76% -$111K ﹤0.01% 1476
2015
Q4 		$144K Sell
2,415
-72
-3% -$4.33K ﹤0.01% 972
2015
Q3 		$134K Sell
2,487
-295
-11% -$17.2K ﹤0.01% 979
2015
Q2 		$159K Sell
2,782
-153
-5% -$8.54K 0.01% 953
2015
Q1 		$175K Sell
2,935
-826
-22% -$44K 0.01% 916
2014
Q4 		$199K Sell
3,761
-15
-0.4% -$750 0.01% 869
2014
Q3 		$168K Sell
3,776
-509
-12% -$21.6K 0.01% 930
2014
Q2 		$180K Sell
4,285
-138
-3% -$5.91K 0.01% 935
2014
Q1 		$193K Buy
4,423
+360
+9% +$16.9K 0.01% 893
2013
Q4 		$199K Sell
4,063
-227
-5% -$10.6K 0.01% 839
2013
Q3 		$176K Sell
4,290
-46
-1% -$1.75K 0.01% 732
2013
Q2 		$152K Buy
+4,336
New +$143K 0.01% 742

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.A. Davidson & Co's WST Position: Q1 2026 in Review

D.A. Davidson & Co reduced its West Pharmaceutical (WST) stake by 2% in Q1 2026, selling an estimated $4.23K and leaving 849 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #1470.

D.A. Davidson & Co first reported a position in WST in Q2 2013 and has held it in 27 quarters since. The position peaked at $468K in Q1 2019. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • D.A. Davidson & Co held 849 shares of West Pharmaceutical worth $213K as of Q1 2026.
  • D.A. Davidson & Co sold 17 West Pharmaceutical shares in Q1 2026, an estimated $4.23K.
  • West Pharmaceutical made up ﹤0.01% of D.A. Davidson & Co's portfolio in Q1 2026, its #1470 holding.
  • D.A. Davidson & Co first reported a position in West Pharmaceutical in Q2 2013 and has held it in 27 quarters since.
  • D.A. Davidson & Co's West Pharmaceutical position peaked at $468K in Q1 2019.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.